evodiamine has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Zhou, Y | 1 |
| Chen, L; Deng, ZL; He, BC; Ke, ZY; Liu, Y; Meng, ZJ; Pi, CJ; Shu, KJ; Wu, N; Yin, LJ; Zhang, RX; Zou, X | 1 |
2 other study(ies) available for evodiamine and Osteosarcoma
| Article | Year |
|---|---|
Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; MAP Kinase Signaling System; Neoplasm Invasiveness; Osteosarcoma; Proto-Oncogene Proteins c-raf; Quinazolines; Signal Transduction | 2018 |
Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction | 2015 |